H.R. 3285 · 118th Congress

Fairness for Patient Medications Act

Introduced on May 15, 2023 by H. Morgan Griffith (R-VA-9). 8 cosponsors, all from the sponsor's party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
May 15, 2023
Cosponsors
8
0 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To establish patient protections with respect to highly rebated drugs.

Subjects

  • Drug safety, medical device, and laboratory regulation
  • Health care costs and insurance
  • Prescription drugs

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

H. Morgan GriffithR-VA-9Sponsor

Republicans · 8

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. May 15, 2023Introduced in House
  2. May 15, 2023Introduced in House
  3. May 15, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. May 15, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. May 15, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  6. May 15, 2023 · HouseReferred to the Subcommittee on Health.
  7. May 17, 2023 · HouseSubcommittee Consideration and Mark-up Session Held.
  8. May 17, 2023 · HouseForwarded by Subcommittee to Full Committee by Voice Vote .
  9. Dec 17, 2024 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. MERCK & CO., INC.10 reports
    $11.1M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  2. BRISTOL-MYERS SQUIBB COMPANY7 reports
    $8M reported (all issues)Federal contractor: BRISTOL-MYERS SQUIBB COMPANY$8.8M in contracts, FY2026AI match · 100%
  3. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA7 reports
    $16M reported (all issues)
  4. CVS HEALTH5 reports
    $11M reported (all issues)
  5. KAISER FOUNDATION HEALTH PLAN INC.5 reports
    $2.9M reported (all issues)Federal contractor: KAISER FOUNDATION HEALTH PLAN OF WASHINGTONAI match · 97%
  6. Pharmaceutical Research and Manufacturers of America (PhRMA)5 reports
    $200K reported (all issues)
  7. SANOFI US SERVICES INC5 reports
  8. TAKEDA PHARMACEUTICALS AMERICA, INC.5 reports
    Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  9. The Cigna Group and subsidiaries (Formerly Cigna Corporation5 reports
    $10.2M reported (all issues)
  10. NOVARTIS CORPORATION4 reports
    $6.2M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  11. Cigna Corporation2 reports
    $180K reported (all issues)Federal contractor: CIGNA WORLDWIDE INSURANCE BRANCH$2.5M in contracts, FY2026AI match · 99%
  12. GSK (fka GLAXOSMITHKLINE INC.)2 reports
    $2.3M reported (all issues)
  13. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2 reports
    $10.1M reported (all issues)
  14. AMERICAN PHARMACIES, INC.1 report
    $60K reported (all issues)

Reports filed in 2023, 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.